clinical trial · NCT06172257
A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 2)
Oculis·phase3·active not recruiting·n = 401
Diabetic Macular EdemaDexamethasone ophthalmic suspension (OCS-01)Vehicle
brief summary
The primary objective of this study is to evaluate the efficacy and safety of the topical ophthalmic administration of OCS 01 as compared to Vehicle in participants with Diabetic Macular Edema (DME).
started
Mar 15, 2024
primary completion
Apr 1, 2026
completion
Apr 1, 2026
last updated
Jan 13, 2026
detailed description
A Phase 3 Pivotal Double-masked, Randomized, Vehicle-controlled, Multicenter Study of the Efficacy and Safety of OCS 01 Eye Drops in participants with Diabetic Macular Edema
official title
A Phase 3 Double-masked, Randomized, Multicenter Study of the Efficacy and Safety of OCS 01 Eye Drops in Subjects With Diabetic Macular Edema
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol